The federal government is investing $75 million in a partnership between Canadian Blood Services and the Canadian Armed Forces aimed at strengthening Canada’s emergency preparedness and ensuring reliable access to critical blood products during military operations.
The funding was announced Thursday by Industry Minister Mélanie Joly and Defence Minister David McGuinty.
The investment will support the development of new blood and plasma capabilities through Canadian Blood Services, helping Canada respond more effectively to health emergencies, natural disasters and military deployments both at home and abroad.
Strengthening emergency preparedness
Federal officials said the project will enhance Canada’s ability to produce and supply blood products domestically during crises, reducing reliance on international supply chains and improving access to critical medical resources.
Blood products play a vital role in trauma care, emergency response and military medical operations.
The government said the initiative will also support operations in remote and challenging environments, including Canada’s North and Arctic regions.
“In an increasingly uncertain world, Canada must be ready to protect the health and safety of Canadians,” Joly said in a statement.
“Our investment in Canadian Blood Services will strengthen our domestic life sciences capabilities, secure critical blood supplies for our armed forces wherever they serve, and ensure we can respond quickly to emergencies, at home and abroad.”
Related Stories:
Expanding domestic production
The funding will help Canadian Blood Services advance innovative blood product technologies and expand domestic manufacturing capacity.
Officials said the project is designed to ensure critical supplies remain available during emergencies while supporting Canada’s broader health security objectives.
Dr. Graham Sher, chief executive officer of Canadian Blood Services, said the investment will strengthen the organization’s ability to adapt to evolving needs in both civilian and military settings.
“As part of Canada’s national critical infrastructure, Canadian Blood Services must be ready to respond when and where needed,” Sher said.
Supporting military operations
The Canadian Armed Forces rely on blood products to support personnel during deployments, training exercises and emergency response operations.
Major-General Scott Malcolm, the Canadian Armed Forces surgeon general, said the investment will improve military medical readiness while also strengthening Canada’s overall health-care resilience.
“Not only are we improving health care for Canadians today, we are also investing in preparedness to support the Canadian Armed Forces well into the future,” Malcolm said.
Part of broader defence strategy
The funding will be delivered through the federal Life Sciences Fund and supports objectives outlined in Canada’s Defence Industrial Strategy.
The federal government said investments in domestic life sciences and health-care infrastructure are increasingly important as countries work to secure critical supply chains and respond to evolving global threats.
The announcement comes days after Prime Minister Mark Carney’s government confirmed Canada had reached NATO’s target of spending two per cent of gross domestic product on defence.
Canadian Blood Services operates the country’s national blood and plasma supply system and is responsible for collecting, testing and distributing blood products to hospitals and health-care providers across Canada.